Detalhe da pesquisa
1.
Extensive red blood cell matching considering patient alloimmunization risk.
Vox Sang
; 119(4): 368-376, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38286764
2.
The added value of ferritin levels and genetic markers for the prediction of haemoglobin deferral.
Vox Sang
; 118(10): 825-834, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37649369
3.
Why the majority of on-site repeat donor deferrals are completely unwarranted .
Transfusion
; 62(10): 2068-2075, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053780
4.
A robust autonomous method for blood demand forecasting.
Transfusion
; 62(6): 1261-1268, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383944
5.
Determining optimal locations for blood distribution centers.
Transfusion
; 62(12): 2515-2524, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239229
6.
Predicting vasovagal reactions to a virtual blood donation using facial image analysis.
Transfusion
; 62(4): 838-847, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191034
7.
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply.
Vox Sang
; 117(11): 1262-1270, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102148
8.
Preventing alloimmunization using a new model for matching extensively typed red blood cells.
Vox Sang
; 117(4): 580-586, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725840
9.
Extended red blood cell matching for all transfusion recipients is feasible.
Transfus Med
; 32(3): 221-228, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845765
10.
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach.
Transfus Med
; 32(5): 366-374, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668008
11.
A WHO tool for risk-based decision making on blood safety interventions.
Transfusion
; 61(2): 503-515, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368381
12.
Not a crystal ball: Mapping opportunities and threats for the future demand of red blood cells in the Netherlands using a scenario approach.
Transfusion
; 61(8): 2356-2367, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34058022
13.
Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands.
Transfusion
; 61(3): 713-721, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528025
14.
West Nile virus and blood transfusion safety: A European perspective.
Vox Sang
; 116(10): 1094-1101, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33900632
15.
First results of a ferritin-based blood donor deferral policy in the Netherlands.
Transfusion
; 60(8): 1785-1792, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32533600
16.
An assessment of the risk, cost-effectiveness, and perceived benefits of anti-parvovirus B19 tested blood products.
Transfusion
; 59(7): 2352-2360, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31032994
17.
The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis.
Value Health
; 21(2): 203-209, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29477402
18.
Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands.
Transfusion
; 57(2): 258-266, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28144956
19.
Validation of multisource electronic health record data: an application to blood transfusion data.
BMC Med Inform Decis Mak
; 17(1): 107, 2017 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28709453
20.
A consensus-based tool for ranking the risk of blood-transmissible infections.
Transfusion
; 56(8): 2108-14, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27217225